Medical cannabis refers to the use of the cannabis plant or its extracts to treat symptoms of illness and other conditions. Its active compounds, primarily cannabinoids like tetrahydrocannabinol (THC) and cannabidiol (CBD), interact with the body’s endocannabinoid system to help regulate a range of physiological processes. Medical cannabis is used for its therapeutic advantages, as it is known to help in pain relief, reduce nausea and vomiting, appetite stimulation, and manage many chronic conditions like multiple sclerosis and epilepsy. The use of medical cannabis is subject to legal regulations, which vary significantly by country and state and often require a prescription from a healthcare provider. Research on its efficacy and safety is ongoing, which has shown its utility in treating many ailments where conventional treatments are not proven as effective or carry significant side effects.
The global medical cannabis market size reached US$ 34.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 66.7 Billion by 2032, exhibiting a growth rate (CAGR) of 7.4% during 2024-2032.
Request for a sample copy of this report: https://www.imarcgroup.com/medical-cannabis-market/requestsample
In this industry, Canopy Growth Corporation stands as one of the biggest and most recognizable names. This business has been actively seeking alliances and acquisitions to widen its reach and range of products around the world. For instance, Canopy partnered with large beverage firms to learn about the possibilities of beverages laced with cannabis. It has also been stressing research and development (R&D) and allocating cash for the creation of fresh cannabis-based medications and delivery methods. This involves conducting clinical studies to determine the efficacy and safety of their drugs, as doing so is essential to receiving regulatory body clearance and being accepted by the medical community.
Tilray has also been expanding its footprint via strategic mergers and acquisitions. In the year 2021, Tilray merged with Aphria Inc. to create one of the world’s largest cannabis companies. This merger gave Tilray access to leverage Aphria’s broad distribution network and production facilities, which has helped the company enhance its capacity. Furthermore, Tilray has been concentrating on extending its portfolio, particularly in the areas of medical cannabis oils and capsules, which are believed to be more patient-friendly than other traditional smoking or vaping variations. Another significant company in this market that has been accomplishing outstanding achievements is Aurora Cannabis. The firm has been concentrating on growing its global footprint, primarily aiming for Europe and Latin America because of its changing regulatory environments.
Read Full Blog: https://www.imarcgroup.com/top-medical-cannabis-companies
List of Top Medical Cannabis companies Worldwide:
- Canopy Growth Corporation
- GW Pharmaceuticals, plc
- Aurora Cannabis, Inc.
- Aphria, Inc.
- MedReleaf Corporation
- Insys Therapeutics, Inc.
- CanniMed Therapeutics, Inc.
- Cara Therapeutics, Inc.
- United Cannabis Corporation
Ask Analyst for Customization and Browse full report with TOC & List of Figures: https://www.imarcgroup.com/request?type=report&id=1053&flag=C
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Email: sales@imarcgroup.com
LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/
